Skip to main content

Sidekick Bio

This biopharmaceutical company develops therapies that modulate the gut microbiome to enhance the safety and efficacy of cancer immunotherapy. Their focus is on improving treatment outcomes and quality of life for oncology patients. The goal is to enable more patients to achieve a durable response to existing cancer treatments.

Boston, United States · HQ
Founded 20225200+ followers
  • Biotechnology
  • Digital Health
Updated 6 months ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • This biopharmaceutical company develops therapies that modulate the gut microbiome to enhance the safety and efficacy of cancer immunotherapy. Their focus is on improving treatment outcomes and quality of life for oncology patients. The goal is to enable more patients to achieve a durable response to existing cancer treatments.
This profile is AI-generated and may contain inaccuracies.